Calquence (Acalabrutinib) is used for the treatment of patients with lymphoma.

CALQUENCE is a kinase inhibitor indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.

Calquence (Acalabrutinib) suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of Calquence (Acalabrutinib) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the CALQUENCE® (acalabrutinib) capsules medicine cost price in India.

The order for Calquence (Acalabrutinib) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Acalabrutinib (trade name Calquence) is a medication used to treat a type of non-Hodgkin lymphoma known as mantle cell lymphoma. Specifically it is for people who had previously been treated with another therapy.

CALQUENCE® (acalabrutinib) capsules, for oral use. Initial U.S. Approval: 2017

Generic Name: acalabrutinib

Calquence (Acalabrutinib)

CALQUENCE® (acalabrutinib) capsules, for oral use is available.

Get In Touch

Calquence (Acalabrutinib) suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Calquence (Acalabrutinib) on prescription and Import License in Patient's Name only.

For overseas patients, Calquence (Acalabrutinib) can be made available in Send your enquiry to find Calquence (Acalabrutinib) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for Calquence (Acalabrutinib).

AstraZeneca leukemia drug Calquence gets USFDA okay For More Details

FDA approves Calquence for chronic lymphocytic leukemia under international collaboration. For More Details

Channel Partner In India


  • Address:60/4, T&T House. Yusuf Sarai, New Delhi:110016
  • Phone +91-11-26532129
  • Email: IPN, New Delhi


  • Address: #308, Raheja Chambers, 12, Museum Road, Bangalore 560 001
  • Email: IPN, Bangalore


  • Address: 1/A R.G Kar Road, Shayambazar, Kolkata 700004
  • Email: IPN, Kolkata


  • Address: 203-A, 2nd Floor, Tower -11, Felix Square, IBB-2, Sushant Golf city, Lucknow 226030
  • Email: IPN, Lucknow